MEK inhibitor is a potent MEK inhibitor with antitumor potency.
Molecular Weight | 426.51 |
CAS Number | 334951-92-7 |
Solubility (25°C) | DMSO 50 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
[1] Kata Czirbesz, et al. [BRAF-MEK inhibitor therapy in melanoma]
[3] Chao Wang, et al. Hybrids of MEK inhibitor and NO donor as multitarget antitumor drugs
[4] Ufuk Degirmenci, et al. Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Related MEK Products |
---|
Glycinexylidide
Glycinexylidide (GX) is the active metabolite of Lidocaine. |
Xantocillin
Xantocillin (Xanthocillin X) is a marine agent extracted from Penicillium commune, induces autophagy through inhibition of the MEK/ERK pathway. |
MEK-IN-6 hydrate
MEK-IN-6 hydrate is a MEK inhibitor. |
MS934
MS934 is a novel improved VHL-recruiting MEK 1/2 degrader. |
Nedometinib
Nedometinib is a tyrosine kinase inhibitor targeting to MEK1. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.